U.S. Life Sciences Stock News

Definium Therapeutics' lead asset, DT120 ODT, has received FDA Breakthrough Therapy Designation for generalized anxiety disorder. The company is approaching pivotal phase III readouts across multiple late stage trials and has launched a new phase II study in autism spectrum disorder. Definium is also increasing its commercial readiness by expanding leadership and building operational infrastructure as it moves toward a potential launch phase. For investors watching NasdaqGS:DFTX, this...

Earlier this week, OLAPLEX Holdings, Inc. launched No.3PLUS Complete Repair Treatment, a three-minute pre-shampoo product using its patented Bond Building Technology™ and new Damage Defense Cationic Complex, supported by a “Science Never Looked So Good” campaign featuring Chloe Fineman and broad distribution across major retail and online channels. This new treatment extends OLAPLEX’s core bond-repair franchise into a faster, more convenient format, aiming to reinforce its science-led brand...

PDF Solutions (PDFS) is back on radar after the Brown Capital Management Small Company Fund added the stock in Q4 2025, citing its AI-focused analytics and semiconductor supply chain solutions as key attractions. See our latest analysis for PDF Solutions. At a share price of US$33.78, PDF Solutions has seen a 24.65% 90 day share price return and a 50.00% 1 year total shareholder return, suggesting momentum has picked up as investors respond to its AI and semiconductor supply chain story. If...

Twist Bioscience (TWST) is back in focus after announcing a licensing deal with Invenra that brings the B-Body bispecific antibody platform under a co-exclusive arrangement, directly expanding Twist’s antibody discovery service offering. See our latest analysis for Twist Bioscience. The licensing news lands after a strong run, with the latest share price at $46.92, a 30 day share price return of 11.69% and a 90 day share price return of 46.58%. Looking further out, the stock shows a 1 year...

SPS Commerce (NasdaqGS:SPSC) reported earnings per share that were ahead of expectations, highlighting resilient profitability. Shortly after the results, the CEO sold company shares, drawing attention to insider activity. Craig Hallum downgraded the stock, citing a revenue miss and a softer outlook for 2026. SPS Commerce focuses on cloud based supply chain and retail data services, giving retailers and suppliers tools to manage orders and product information. That positions the company in...

If you are wondering whether Mettler-Toledo International remains a quality business at the current price or if the market has moved ahead of the fundamentals, this article will walk you through what the valuation signals are really saying. The stock last closed at US$1,366.69, with a 7 day return showing a 0.8% decline, a 30 day return showing a 2.5% decline, and a 1 year return of 7.4%. Taken together, this offers a mixed picture of recent sentiment and longer term performance. Recent news...

Las Vegas Sands (NYSE:LVS) is supporting the UNLV STEM for Girls Camp, aimed at encouraging girls to pursue science, technology, engineering and math fields. The initiative focuses on expanding access to STEM education for young women in the company’s home region. This support highlights the company’s focus on social responsibility and workforce diversity alongside its core resort and gaming operations. For investors watching Las Vegas Sands at a current share price of $56.72, this new...

PACS Group (PACS) just wrapped up FY 2025 with Q4 revenue of US$1.4b and basic EPS of US$0.38, supported by trailing twelve month revenue of US$5.3b and EPS of US$1.23 that has been tied to very large year on year earnings growth of 243.5%. Over recent periods, the company has seen quarterly revenue move from US$1.21b in Q4 2024 to US$1.36b in Q4 2025, while quarterly EPS went from US$0.24 to US$0.38. This sets up a results season where strong reported earnings growth, margin improvement to...

GeneDx Holdings (NasdaqGS:WGS) Chief Operating Officer Bryan Dechairo has sold his entire direct shareholding in an open market transaction. The sale was executed under a Rule 10b5-1 trading plan and leaves Dechairo with no direct equity interest in the company. This insider transaction comes as GeneDx continues to report business growth and operational progress. The move comes at a time when GeneDx shares last closed at $79.71, with the stock showing mixed performance across time frames...

Warner Bros. Discovery (WBD) has capped FY 2025 with fourth quarter revenue of US$9.5b and a basic EPS loss of US$0.10, setting the tone for a year where profitability on a trailing basis has been supported by a sizeable one off gain. The company has seen quarterly revenue range between US$9.0b and US$9.8b across 2025, with EPS swinging from a loss of US$0.18 in Q1 to a profit of US$0.64 in Q2 before reverting to losses in Q3 and Q4. This leaves investors focusing on how much of the reported...

BrightSpring Health Services (BTSG) just closed FY 2025 with fourth quarter revenue of US$3.6b and basic EPS of US$0.24, while net income from continuing operations, excluding extra items, came in at US$49.3m. The company has seen quarterly revenue move from US$3.1b and EPS of US$0.08 in Q4 2024 to US$3.6b and EPS of US$0.24 in Q4 2025, with trailing twelve month EPS at US$0.53 and net income of US$106.3m on US$12.9b in revenue. This puts the latest report firmly in focus for anyone tracking...

Applied Optoelectronics (AAOI) closed out FY 2025 with fourth quarter revenue of US$134.3 million and a basic EPS loss of US$0.03, alongside net income excluding extra items of a US$2.0 million loss. This puts the focus squarely on how efficiently that top line is being converted into earnings. The company has seen quarterly revenue move from US$65.2 million in Q3 2024 to US$100.3 million in Q4 2024, then to US$99.9 million in Q1 2025, US$103.0 million in Q2 2025, US$118.6 million in Q3 2025...

Perella Weinberg Partners recently reported quarterly revenues of US$219.2 million, a 2.9% year-on-year decline that still exceeded analyst estimates by a very large margin, alongside an earnings beat. The results highlight how the firm’s operational execution outpaced expectations even as headline revenue slipped, offering a more nuanced picture of performance for investors. Next, we’ll examine how this better-than-expected revenue performance shapes Perella Weinberg Partners’ investment...

Community Trust Bancorp recently highlighted a quarterly dividend of US$0.53 per share, implying a 3.43% yield and reflecting five consecutive years of annual dividend increases averaging 5.32%. Alongside this dividend profile, the company is guided by a Zacks Consensus Estimate pointing to fiscal 2026 earnings of US$5.79 per share, suggesting investors are closely watching how income and earnings trends align. With this backdrop of consistent dividend growth, we’ll examine how the company’s...

In February 2026, STAAR Surgical announced that the FDA approved an expanded age indication for its EVO/EVO+ Visian Implantable Collamer Lenses, extending U.S. use from ages 21–45 to 21–60 following three-year safety data. This broader label meaningfully enlarges the potential U.S. candidate pool for EVO ICL, especially among adults aged 46–60 who were previously excluded. We’ll now examine how opening EVO ICL access to patients up to age 60 could reshape STAAR Surgical’s longer-term...

Coupang FY 2025 Results Set Up a Mixed but Margin Focused Story Coupang (CPNG) closed FY 2025 with fourth quarter revenue of US$8.8b and a basic EPS loss of US$0.01, as net income excluding extra items came in at a US$26m loss against a backdrop of growing full year scale. The company has seen quarterly revenue step up from US$7.9b in Q4 2024 to between US$7.9b and US$9.3b through 2025. Basic EPS has moved between a profit of US$0.06 and a small loss in the latest quarter, setting up a TTM...

If you are wondering whether Nova's share price still reflects good value after a strong run, this article is for you. We will walk through what the current market price might be implying about the business. Nova's stock last closed at US$438.86, with a 7 day return of a 0.5% decline, a 30 day return of a 9.9% decline, a year to date return of 26.3% and a 1 year return of 83.5%, while the 3 year return is very large and the 5 year return is also very large. Recent news coverage around Nova...

Opera (NasdaqGS:OPRA) posts FY 2025 results Opera (NasdaqGS:OPRA) closed out FY 2025 with fourth quarter revenue of US$176.7 million and basic EPS of US$0.62, rounding off a trailing twelve month run of US$614.4 million in revenue and EPS of US$1.21 as earnings grew 34.1% over the past year. The company has seen revenue move from US$480.6 million on a trailing basis at the end of 2024 to US$614.4 million by the end of 2025, while trailing net profit margin edged up from 16.8% to 17.6%. With...

Innodata (INOD) has just wrapped up FY 2025 with fourth quarter revenue of US$72.4 million and basic EPS of US$0.28, alongside trailing twelve month revenue of US$251.7 million and EPS of US$1.01. The company has seen quarterly revenue move from US$52.2 million in Q3 2024 to US$72.4 million in Q4 2025. Basic EPS has ranged from US$0.60 in Q3 2024 to between US$0.23 and US$0.28 across the 2025 quarters, setting up a picture where growing sales are rubbing against tighter margins and leaving...

On Holding (NYSE:ONON) is expanding rapidly across Asia-Pacific, adding new markets and strengthening its regional presence. The company is pushing its direct-to-consumer model globally, supported by its own performance footwear and apparel technology. Management is putting capital behind product development and customer engagement, with an eye on premium brand positioning worldwide. On Holding, trading at around $46.48, sits in a premium corner of the sportswear space with a 3 year return...

If you are wondering whether Prologis at around US$142.57 is priced for perfection or offering value, you are in the right place for a clear look at what the current share price might imply. The stock has recent returns of 0.7% over 7 days, 12.1% over 30 days, 10.5% year to date, 19.1% over 1 year, 23.5% over 3 years and 68.4% over 5 years. This naturally raises questions about how much optimism is already reflected in the price. Recent attention around Prologis has focused on its role as a...

Coterra Energy FY 2025 Earnings Snapshot Coterra Energy (CTRA) closed FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$0.48, alongside net income excluding extra items of US$368 million, giving investors a clear read on its latest top and bottom line. Over the past year, the company has seen trailing twelve month revenue move from US$5.2 billion to US$7.3 billion, while trailing EPS shifted from US$1.51 to US$2.26 as net income excluding extra items moved from US$1.1...

Pinnacle West Capital (NYSE:PNW) entered a new $300 million revolving credit facility, replacing its prior arrangement. The facility extends through 2031 and is intended to support general corporate purposes and ongoing infrastructure investments. For investors watching NYSE:PNW, this fresh $300 million credit line arrives with the stock around $100.3 per share, alongside returns of 13.8% year to date and 63.9% over 5 years. These figures provide a snapshot of how the market has valued the...

If you are wondering whether 3M is still a solid value play at its current price, this article walks through what the numbers actually say about the stock. 3M shares last closed at US$165.32, with a 1% decline over the past week, a 6% gain over the last 30 days, and returns of 2.2% year to date, 8.5% over 1 year, a very large gain over 3 years, and 31% over 5 years. Recent headlines around 3M have focused on its ongoing business repositioning and legal overhangs, which continue to shape how...